Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham J Mann

Showing results (21-30 of 194) with videos related to

Pageof 20
Sort By:
Journal of Genetic Counseling|November 15, 2006
Better the devil you know? High-risk individuals' anticipated psychological responses to genetic testing for melanoma susceptibilityNadine A Kasparian, Bettina Meiser, Phyllis N Butow, et al.
Journal of Dermatological Science|April 22, 2020
Proteomics: An emerging approach for the diagnosis and classification of cutaneous squamous cell carcinoma and its precursorsAli Azimi, Kimberley L Kaufman, Jennifer Kim, et al.
The Journal of Investigative Dermatology|September 30, 2011
Review and cross-validation of gene expression signatures and melanoma prognosisSarah-Jane Schramm, Anna E Campain, Richard A Scolyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2016
Cost-Effectiveness of Skin Surveillance Through a Specialized Clinic for Patients at High Risk of MelanomaCaroline G Watts, Anne E Cust, Scott W Menzies, et al.
Psycho-Oncology|July 29, 2006
Anticipated uptake of genetic testing for familial melanoma in an Australian sample: An exploratory studyNadine A Kasparian, Bettina Meiser, Phyllis N Butow, et al.
Experimental Dermatology|November 14, 2022
Genomic and proteomic findings in early melanoma and opportunities for early diagnosisRachel Teh, Ali Azimi, Gulietta M Pupo, et al.
Breast Cancer Research : BCR|June 10, 2006
Variation in the RAD51 gene and familial breast cancerFelicity Lose, Paul Lovelock, Georgia Chenevix-Trench, et al.
Journal of Cutaneous Pathology|May 24, 2007
Low prevalence of RAS-RAF-activating mutations in Spitz melanocytic nevi compared with other melanocytic lesionsJames O Indsto, Swapna Kumar, Lixiang Wang, et al.
BMJ Open|January 10, 2012
The COMPASs Study: Community Preferences for Prostate cAncer Screening. Protocol for a quantitative preference studyKirsten Howard, Glenn P Salkeld, Graham J Mann, et al.
Psycho-Oncology|May 26, 2011
The nature and structure of psychological distress in people at high risk for melanoma: a factor analytic studyNadine A Kasparian, Ursula Sansom-Daly, Roderick P McDonald, et al.
Pageof 20

Showing results (21-30 of 194) with videos related to

Sort By:
Pageof 20
Journal of Genetic Counseling|November 15, 2006
Better the devil you know? High-risk individuals' anticipated psychological responses to genetic testing for melanoma susceptibilityNadine A Kasparian, Bettina Meiser, Phyllis N Butow, et al.
Journal of Dermatological Science|April 22, 2020
Proteomics: An emerging approach for the diagnosis and classification of cutaneous squamous cell carcinoma and its precursorsAli Azimi, Kimberley L Kaufman, Jennifer Kim, et al.
The Journal of Investigative Dermatology|September 30, 2011
Review and cross-validation of gene expression signatures and melanoma prognosisSarah-Jane Schramm, Anna E Campain, Richard A Scolyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2016
Cost-Effectiveness of Skin Surveillance Through a Specialized Clinic for Patients at High Risk of MelanomaCaroline G Watts, Anne E Cust, Scott W Menzies, et al.
Psycho-Oncology|July 29, 2006
Anticipated uptake of genetic testing for familial melanoma in an Australian sample: An exploratory studyNadine A Kasparian, Bettina Meiser, Phyllis N Butow, et al.
Experimental Dermatology|November 14, 2022
Genomic and proteomic findings in early melanoma and opportunities for early diagnosisRachel Teh, Ali Azimi, Gulietta M Pupo, et al.
Breast Cancer Research : BCR|June 10, 2006
Variation in the RAD51 gene and familial breast cancerFelicity Lose, Paul Lovelock, Georgia Chenevix-Trench, et al.
Journal of Cutaneous Pathology|May 24, 2007
Low prevalence of RAS-RAF-activating mutations in Spitz melanocytic nevi compared with other melanocytic lesionsJames O Indsto, Swapna Kumar, Lixiang Wang, et al.
BMJ Open|January 10, 2012
The COMPASs Study: Community Preferences for Prostate cAncer Screening. Protocol for a quantitative preference studyKirsten Howard, Glenn P Salkeld, Graham J Mann, et al.
Psycho-Oncology|May 26, 2011
The nature and structure of psychological distress in people at high risk for melanoma: a factor analytic studyNadine A Kasparian, Ursula Sansom-Daly, Roderick P McDonald, et al.
Pageof 20